+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bone Growth Stimulators Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • PDF Icon

    Report

  • 83 Pages
  • July 2024
  • Region: Global
  • GlobalData
  • ID: 5851550
The Medical Devices sector report, “Bone Growth Stimulators Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Bone Growth Stimulators pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Bone growth stimulators are mainly used to facilitate bone growth in impaired or delayed healing fractures/fusions. Bone growth stimulators apply electrical or ultrasound waves to the site of the fracture/fusion.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Bone Growth Stimulators under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Bone Growth Stimulators and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to :

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Bone Growth Stimulators under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Bone Growth Stimulators Overview
3 Products under Development
3.1 Bone Growth Stimulators - Pipeline Products by Stage of Development
3.2 Bone Growth Stimulators - Pipeline Products by Segment
3.3 Bone Growth Stimulators - Pipeline Products by Territory
3.4 Bone Growth Stimulators - Pipeline Products by Regulatory Path
3.5 Bone Growth Stimulators - Pipeline Products by Estimated Approval Date
3.6 Bone Growth Stimulators - Ongoing Clinical Trials
4 Bone Growth Stimulators - Pipeline Products under Development by Companies
4.1 Bone Growth Stimulators Companies - Pipeline Products by Stage of Development
4.2 Bone Growth Stimulators - Pipeline Products by Stage of Development
5 Bone Growth Stimulators Companies and Product Overview6 Bone Growth Stimulators- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Analyst
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Bone Growth Stimulators - Pipeline Products by Stage of Development
  • Bone Growth Stimulators - Pipeline Products by Segment
  • Bone Growth Stimulators - Pipeline Products by Territory
  • Bone Growth Stimulators - Pipeline Products by Regulatory Path
  • Bone Growth Stimulators - Pipeline Products by Estimated Approval Date
  • Bone Growth Stimulators - Ongoing Clinical Trials
  • Bone Growth Stimulators Companies - Pipeline Products by Stage of Development
  • Bone Growth Stimulators - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Bone Growth Stimulators - Pipeline Products by Stage of Development
  • Bone Growth Stimulators - Pipeline Products by Segment
  • Bone Growth Stimulators - Pipeline Products by Territory
  • Bone Growth Stimulators - Pipeline Products by Regulatory Path
  • Bone Growth Stimulators - Pipeline Products by Estimated Approval Date
  • Bone Growth Stimulators - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Bionext Biotech Products Ltd.
  • Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine
  • Collamedix Inc
  • Curative Biosciences, Inc.
  • DJO Global Inc
  • Eepta Pty Ltd
  • GreenBone Ortho srl
  • Industrie Biomediche Insubri SA
  • Inion Oy
  • Johns Hopkins University
  • KeraCure, Inc. (Inactive)
  • Lattice Biologics Ltd
  • Magle Chemoswed AB
  • Max Biopharma Inc
  • NC Biomatrix BV
  • NDSU Research Foundation
  • Oklahoma State University
  • Oligo Medic Inc
  • Orthocell Ltd
  • Orthofix Medical Inc
  • OsteoGenix Incorporated (Inactive)
  • REGENECURE Ltd
  • Texas A&M University
  • The University of Nottingham
  • Universiti Putra Malaysia
  • University of California Davis
  • University of Florida
  • University of Wisconsin Madison
  • Wright Medical Group NV (Inactive)
  • ZetaGen Therapeutics Inc